Histones and long non-coding RNAs: the new insights of epigenetic deregulation involved in oral cancer
- PMID: 24844984
- DOI: 10.1016/j.oraloncology.2014.04.006
Histones and long non-coding RNAs: the new insights of epigenetic deregulation involved in oral cancer
Abstract
Oral squamous cell carcinoma (OSCC) is a category of aggressive malignancies that represent clinically, molecularly, and etiologically heterogeneous tumors. The majority of OSCCs are associated with tobacco and alcohol use, acting both independently and synergistically, which suggests that the environment plays an important role in carcinogenesis; however, the mechanisms associated with the development of OSCC are not well understood. It has been proposed that the epigenetic components could be implicated in the initiation and progression of OSCC. Primarily, aberrant DNA methylation patterns have been widely addressed in the study of OSCC. Diverse studies have proposed that other epigenetic processes such as post-translational histone modification, the deposition of histone variants, histone chaperones, and recently non-coding RNA, can be also involved in the development of oral cancer. In this review we focus on describing the new insights of the epigenetics processes that are related with OSCC as histones variants and long non-coding RNAs.
Keywords: Epigenetics; Histones; Long non-coding RNA; Oral cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Emerging role of non-coding RNA in oral cancer.Cell Signal. 2018 Jan;42:134-143. doi: 10.1016/j.cellsig.2017.10.009. Epub 2017 Oct 19. Cell Signal. 2018. PMID: 29056500 Review.
-
DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.Oral Dis. 2011 Nov;17(8):771-8. doi: 10.1111/j.1601-0825.2011.01833.x. Epub 2011 Jul 22. Oral Dis. 2011. PMID: 21781230 Review.
-
Global analysis of DNA methylation changes during progression of oral cancer.Oral Oncol. 2013 Nov;49(11):1033-42. doi: 10.1016/j.oraloncology.2013.08.005. Epub 2013 Sep 13. Oral Oncol. 2013. PMID: 24035722
-
MicroRNAs: new actors in the oral cancer scene.Oral Oncol. 2011 May;47(5):314-9. doi: 10.1016/j.oraloncology.2011.03.019. Epub 2011 Apr 6. Oral Oncol. 2011. PMID: 21474366 Review.
-
Epigenetic mechanisms in oral carcinogenesis.Future Oncol. 2012 Nov;8(11):1407-25. doi: 10.2217/fon.12.138. Future Oncol. 2012. PMID: 23148615 Free PMC article. Review.
Cited by
-
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.Mol Ther. 2020 Oct 7;28(10):2177-2190. doi: 10.1016/j.ymthe.2020.06.024. Epub 2020 Jun 24. Mol Ther. 2020. PMID: 32621798 Free PMC article.
-
Epigenetics: A possible answer to the undeciphered etiopathogenesis and behavior of oral lesions.J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):122-8. doi: 10.4103/0973-029X.180967. J Oral Maxillofac Pathol. 2016. PMID: 27194874 Free PMC article. Review.
-
Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets.J Otolaryngol Head Neck Surg. 2017 Jan 31;46(1):9. doi: 10.1186/s40463-017-0185-3. J Otolaryngol Head Neck Surg. 2017. PMID: 28143553 Free PMC article. Review.
-
Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.J Clin Invest. 2018 Jun 1;128(6):2581-2599. doi: 10.1172/JCI96915. Epub 2018 May 14. J Clin Invest. 2018. PMID: 29757189 Free PMC article.
-
Long non‑coding RNAs are novel players in oral inflammatory disorders, potentially premalignant oral epithelial lesions and oral squamous cell carcinoma (Review).Int J Mol Med. 2020 Aug;46(2):535-545. doi: 10.3892/ijmm.2020.4628. Epub 2020 Jun 3. Int J Mol Med. 2020. PMID: 32626947 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical